Display options
Cite
Shwaylia H, Ali E, Yassin MA. Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera). Case Rep Oncol. 2021;14(2):851-854doi: 10.1159/000515782.
Shwaylia, H., Ali, E., & Yassin, M. A. (2021). Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera). Case reports in oncology, 14(2), 851-854. https://doi.org/10.1159/000515782
Shwaylia, Hawraa, et al. "Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)." Case reports in oncology vol. 14,2 (2021): 851-854. doi: https://doi.org/10.1159/000515782
Shwaylia H, Ali E, Yassin MA. Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera). Case Rep Oncol. 2021 Jun 11;14(2):851-854. doi: 10.1159/000515782. eCollection 2021. PMID: 34248550; PMCID: PMC8255747.
Copy Download .nbib Format: NLM
Share it on

Case Rep Oncol. 2021 Jun 11;14(2):851-854. doi: 10.1159/000515782. eCollection 2021.

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera).

Case reports in oncology

Hawraa Shwaylia, Elrazi Ali, Mohamed A Yassin

Affiliations

  1. Department of Medical Oncology, Hamad Medical Corporation, Doha, Qatar.
  2. Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.

PMID: 34248550 PMCID: PMC8255747 DOI: 10.1159/000515782

Abstract

Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (

Copyright © 2021 by S. Karger AG, Basel.

Keywords: Hepatitis; Hepatitis C; Interferon; Polycythemia vera

Conflict of interest statement

All authors have no conflict of interest.

References

  1. Crit Rev Oncol Hematol. 2016 Sep;105:112-7 - PubMed
  2. Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S27-33 - PubMed
  3. Blood. 2015 Dec 10;126(24):2585-91 - PubMed
  4. Br J Haematol. 2020 Sep;190(6):869-876 - PubMed
  5. N Engl J Med. 2006 Dec 7;355(23):2444-51 - PubMed
  6. Gene. 2019 Mar 20;689:34-42 - PubMed
  7. Cancer Med. 2020 Jul;9(13):4512-4526 - PubMed
  8. Br J Clin Pharmacol. 2008 Feb;65(2):158-62 - PubMed

Publication Types